Table 2.
Intraoperative characteristics
| Characteristic | All patients (n = 231) | QCC+ group (n = 153) | Control group (n = 78) | P value |
|---|---|---|---|---|
| Procedure type | ||||
| CABG | 122/231 (52.8%) | 82/153 (53.6%) | 40/78 (51.3%) | .78 |
| Valve repair/replacement | 72/231 (31.2%) | 44/153 (28.8%) | 28/78 (35.9%) | .30 |
| CABG or valve repair/replacement | 212/231 (91.8%) | 141/153 (92.2%) | 71/78 (91.0%) | .80 |
| Aortic aneurysm surgery | 19/231 (8.2%) | 12/153 (7.8%) | 7/78 (9.0%) | .80 |
| Total operating room time (min) | 252.9 ± 98.2 113.0-677.0 |
249.4 ± 98.3 114.0-677.0 |
260.2 ± 98.4 113.0-582.0 |
.44 |
| Bleeding assessment site | ||||
| Sternal edge | 161/231 (69.7%) | 108/153 (70.6%) | 53/78 (67.9%) | .76 |
| Surgical site | 68/231 (29.4%) | 43/153 (28.1%) | 25/78 (32.1%) | .55 |
| Overall bleed | 2/231 (0.9%) | 2/153 (1.3%) | 0/78 (0.0%) | .55 |
| Initial bleeding assessment | ||||
| Mild/Grade 1 | 93/231 (40.3%) | 62/153 (40.5%) | 31/78 (39.7%) | >.99 |
| Moderate/Grade 2 | 138/231 (59.7%) | 91/153 (59.5%) | 47/78 (60.3%) | >.99 |
| Blood product | ||||
| Red blood cell | 45/231 (19.5%) | 30/153 (19.6%) | 15/78 (19.2%) | >.99 |
| Fresh-frozen plasma | 17/231 (7.4%) | 11/153 (7.2%) | 6/78 (7.7%) | >.99 |
| Cryoprecipitate | 26/231 (11.3%) | 12/153 (7.8%) | 14/78 (17.9%) | .03 |
| Platelets | 51/231 (22.1%) | 29/153 (19.0%) | 22/78 (28.2%) | .13 |
| Any blood product | 76/231 (32.9%) | 47/153 (30.7%) | 29/78 (37.2%) | .38 |
Data expressed as n (%), mean ± standard deviation, min-max. QCC+, QuikClot Control+; CABG, coronary artery bypass grafting.